ADVANCED SOLID TUMOURS
Clinical trials for ADVANCED SOLID TUMOURS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOURS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug combo enters human testing for tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called PYX-201 in combination with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors. The main goals are to find the safest and most effective dose and to see how well the body handles the two drugs togeth…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1, PHASE2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug aims to fight cancer while protecting the heart
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new drug called RC220 when given with the common chemotherapy drug doxorubicin. It will involve about 53 adults with advanced solid tumors who may benefit from anthracycline treatment. The main goals are to find the safest do…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Race Oncology Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cancer drug trial seeks first human volunteers
Disease control Recruiting nowThis is an early-stage study to test the safety of a new drug called EBC-129 in people with advanced solid tumors that have stopped responding to standard treatments. Researchers will first test EBC-129 by itself to find a safe dose, then test it combined with an existing immunot…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called LM-168, both alone and combined with an existing immunotherapy drug (toripalimab), in people with advanced solid tumors that have stopped responding to standard treatments. The first phase checks for safety and determines the ri…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope drug enters first human tests for tough cancers
Disease control Recruiting nowThis is the first study in people to test a new cancer drug called SIM0610. It aims to find a safe dose and see if it can shrink tumors in adults with advanced solid cancers that have stopped responding to standard treatments. The study will enroll 260 people with cancers like lu…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in humans testing a new cancer drug called AZD9592. Researchers want to find safe doses and see if it helps control advanced cancers like lung, head/neck, and colorectal tumors. The study will test AZD9592 alone and combined with other cancer treatments in…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC